TrialThe New England journal of medicine2021

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19.

Peter Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.